Team Health Holdings, Inc. Announces Fourth Quarter and Fiscal 2013 Financial Results - WBOC-TV 16, Delmarvas News Leader, FOX 21 -

Team Health Holdings, Inc. Announces Fourth Quarter and Fiscal 2013 Financial Results

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Team Health Holdings, Inc.

KNOXVILLE, Tenn., Feb. 11, 2014 /PRNewswire/ --

2013 Fourth Quarter Highlights

  • Net revenue increased to $621.8 million; 14.1% over the prior year fourth quarter
  • Net earnings attributable to Team Health Holdings, Inc. ("Net earnings") were $21.5 million; $32.7 million after adjustments
  • Diluted net earnings per share of $0.30; Adjusted EPS of $0.46
  • Adjusted EBITDA increased 14.5% to $61.9 million
  • 2014 net revenue growth guidance of 11% to 12%, which includes the benefit from Medicaid parity, but excludes other potential benefits from healthcare reform

Team Health Holdings, Inc. ("TeamHealth" or the "Company") (NYSE: TMH), one of the largest providers of outsourced physician staffing solutions for hospitals in the United States, today announced results for its fourth quarter and full fiscal year of 2013.

"We are pleased with our financial performance for the fourth quarter of 2013. In a challenging volume environment, we continued to deliver solid growth in net revenue, Adjusted EBITDA, and Adjusted EPS. As a result of our operating focus, for the full year we generated 15.2% top line growth and 10.5% Adjusted EBITDA margin," said TeamHealth Chief Executive Officer, Greg Roth.

"Our performance in 2013 demonstrates the resiliency of our balanced and integrated approach to achieving our financial goals. Despite the headwind from same contract volume declines, we realized positive contributions from all three elements of our revenue growth profile. For the fourth quarter, acquisitions provided the largest component of our consolidated revenue growth as we saw a benefit from 13 acquisitions that were completed in 2013 and late 2012. Net new contract growth was the second largest contributor over the quarter, driven by strong performance in new contract sales. Finally, same contract revenue contributed to growth during the quarter, driven primarily by contributions from Medicaid parity and an increase in estimated collections per visit. As we move into 2014, we remain well positioned with a solid acquisition pipeline and are poised to benefit from healthcare reform.   As such, for 2014 we expect to deliver annual net revenue growth of between 11% and 12%, including the benefit from Medicaid parity, and project Adjusted EBITDA margin for the full year of 2014 to be approximately 10.5%. We expect Medicaid parity to contribute between $26 million and $28 million of revenue for 2014.  Our guidance does not include other benefits that we may see from healthcare reform. These benefits include potential increases in average collection rates from an improvement in our payor mix or incremental volume growth from newly insured patients.  At this initial stage of the implementation process, we believe it is too early to accurately forecast the number of patients to be converted during the year and the potential benefits to the Company's 2014 financial results from the expansion of healthcare coverage. We anticipate having additional visibility as the enrollment process continues to unfold during 2014 and will provide updates at that time," concluded Mr. Roth.

Lynn Massingale, M.D., Executive Chairman of TeamHealth, added, "We are pleased with the successful execution of our growth plan in 2013 and we look forward to delivering strong operating and financial performance in 2014.  We continued to utilize our national infrastructure and strong physician leadership to drive operational improvements across our growing network of high quality affiliated providers, while making investments in patient safety, risk management, operational efficiency and customer satisfaction.  Our priority is to deliver the highest quality of patient care and our proprietary information technology systems and infrastructure investments enable us to accomplish these goals."

2013 Fourth Quarter Results

Net revenue increased 14.1% to $621.8 million from $544.8 million in the fourth quarter of 2012.  Acquisitions contributed 9.1%, net sales growth contributed 2.8%, and same contract revenue contributed 2.2% of the increase in quarter-over-quarter growth in net revenue. 

Same contract revenue increased $12.2 million, or 2.4%, to $512.6 million from $500.4 million in the fourth quarter of 2012.  An increase of 7.6% in estimated collections on fee for service visits provided a 5.2% increase in same contract revenue growth between quarters while a 3.2% decrease in same contract volumes constrained growth by 2.3%.  Contract and other revenue constrained same contract revenue growth between quarters by 0.5%. Acquisitions contributed $49.6 million of revenue growth, and net new contract revenue increased by $15.2 million between quarters.  The benefit from Medicaid parity revenue recognized in the fourth quarter was $12.9 million, of which $12.2 million is same contract revenue.  Medicaid parity contributed 2.4% to both consolidated revenue growth and same contract revenue growth between quarters.  Medicaid parity revenue benefited from favorable developments regarding provider eligibility in several key states during the fourth quarter. 

Reported net earnings for the quarter were $21.5 million, or $0.30 diluted net earnings per share, compared to net earnings of $14.8 million, or $0.21 diluted net earnings per share, in the fourth quarter of 2012.  The financial results for the fourth quarter of 2013 included $5.4 million of contingent purchase and other acquisition compensation expense ($4.1 million after-tax) and non-cash amortization expense of $10.5 million ($7.1 million after tax).  Excluding these items, net earnings for the fourth quarter of 2013 would have been $32.7 million and Adjusted EPS would have been $0.46 per share.  Financial results for the fourth quarter of 2012 included $10.7 million of contingent purchase and other acquisition compensation expense ($6.6 million after-tax), non-cash amortization expense of $8.3 million ($5.3 million after-tax) and a loss on refinancing of debt of $0.2 million ($0.1 million after-tax).  Excluding these items, net earnings for the fourth quarter of 2012 would have been $26.8 million and Adjusted EPS would have been $0.39 per share.  See "Non-GAAP Financial Measures Reconciliations" and "Adjusted Earnings Per Share" below for the definition of Adjusted EPS and its reconciliation to net earnings and diluted earnings per share attributable to Team Health Holdings, Inc.

Cash flow provided by operations for the quarter was $39.7 million compared to $48.0 million in the fourth quarter of 2012.  There were $28.5 million of contingent purchase payments made in the fourth quarter of 2013 and $13.5 million in 2012.  Excluding the impact of these items, operating cash flow in 2013 was $68.3 million compared to $61.4 million, reflecting an increase of $6.9 million between quarters. 

Adjusted EBITDA for the quarter increased 14.5% to $61.9 million from $54.1 million in the fourth quarter of 2012, and Adjusted EBITDA margin was 9.9% in both quarters. See "Non-GAAP Financial Measures Reconciliations" and "Adjusted EBITDA" below for the definitions of Adjusted EBITDA Margin and Adjusted EBITDA and its reconciliation to net earnings attributable to Team Health Holdings, Inc.

As of December 31, 2013, the Company had cash and cash equivalents of approximately $32.3 million and $250.0 million of available borrowings under its revolving credit facility (without giving effect to $6.1 million of undrawn letters of credit).  The Company's total outstanding debt was $501.6 million as of December 31, 2013.

Fiscal 2013 Full Year Results

Net revenue for the twelve months ended December 31, 2013 increased 15.2% to $2.38 billion from $2.07 billion for the same period of 2012.  Acquisitions contributed 9.1%, net sales growth contributed 3.3%, and same contract revenue contributed 2.9% of the increase in year-over-year growth in net revenue.

Same contract revenue for the twelve months ended December 31, 2013 increased $59.0 million, or 3.5%, to $1.73 billion from $1.67 billion in the same period a year ago.  Increases in estimated collections on fee for service visits of 6.7% provided a 5.0% increase in same contract revenue growth compared to the same period in 2012.  Fee for service volume declines constrained growth in same contract revenue  by 1.2% as the number of visits decreased 1.6% from the same contract volume reported in the twelve months ended December 31, 2012.  Contract and other revenue constrained same contract revenue growth between years by 0.3%.  Acquisitions contributed $187.9 million of growth, and net new contract revenue increased by $67.6 million between periods.  The benefit from Medicaid parity revenue recognized for fiscal 2013 was $25.9 million, of which $21.2 million is same contract revenue.  Medicaid parity revenue contributed 1.3%  to both consolidated revenue growth and same contract revenue growth between years.

Reported net earnings were $87.4 million in the twelve months ended December 31, 2013, or $1.24 diluted net earnings per share, compared to net earnings of $63.8 million, or $0.93 diluted net earnings per share, in 2012.  The 2013 financial results included $24.0 million ($16.6 million after-tax) of contingent purchase and other acquisition compensation expense and non-cash amortization expense of $37.6 million ($25.0 million after-tax).  Excluding these items, net earnings for 2013  would have been $129.0 million and Adjusted EPS would have been $1.83 per share.  Financial results for 2012 included $36.9 million ($22.8 million after-tax) of contingent purchase and other acquisition compensation expense, non-cash amortization expense of $29.8 million ($18.9 million after-tax), a loss on refinancing of debt of $0.2 million ($0.1 million after-tax) and an increase in prior year professional liability loss reserves of $5.2 million ($3.1 million after-tax).  Excluding these adjustments, net earnings for 2012 would have been $108.7 million and Adjusted EPS would have been $1.59 per share.  See "Non-GAAP Financial Measures Reconciliations" and "Adjusted Earnings Per Share" below for the definition of Adjusted EPS and its reconciliation to net earnings and diluted earnings per share.

Cash flow provided by operations for the twelve months ended December 31, 2013 was $154.4 million compared to $71.6 million in 2012. Included in operating cash flows were contingent purchase payments of $29.1 million in 2013 and $31.4 million in 2012.  Also included in operating cash flows in 2012 were $37.3 million in premium payments to a commercial insurance carrier in connection with a loss portfolio transfer by the Company's insurance subsidiary.

Excluding the impact of the contingent purchase and loss transfer payments, operating cash flow in 2013 was $183.5 million compared to $140.2 million in 2012, reflecting an increase of $43.3 million between years.

Adjusted EBITDA for the year increased 15.1% to $251.3 million from $218.2 million for the twelve months ended December 31, 2012, and Adjusted EBITDA margin was 10.5% in both  2013 and 2012.  See "Non-GAAP Financial Measures Reconciliations" and "Adjusted EBITDA" below for the definitions of Adjusted EBITDA Margin and Adjusted EBITDA and its reconciliation to net earnings attributable to Team Health Holdings, Inc.

Conference Call

As previously announced, TeamHealth will hold a conference call tomorrow, February 12, 2014, to discuss its fourth quarter and fiscal 2013 results at 8:30 a.m. (Eastern Time).  The conference call can be accessed live over the phone by dialing 1-877-407-0784, or for international callers, 1-201-689-8560.  A replay will be available one hour after the call and can be accessed by dialing 1-877-870-5176, or for international callers, 1-858-384-5517.  The passcode for the live call and the replay is 13575146. The replay will be available until February 19, 2014.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at www.teamhealth.com.  The on-line replay will remain available for a limited time beginning immediately following the call.

To learn more about TeamHealth, please visit the company's Web site at www.teamhealth.com.   TeamHealth uses its Web site as a channel of distribution for material Company information.  Financial and other material information regarding TeamHealth is routinely posted on the Company's Web site and is readily accessible.

About TeamHealth

TeamHealth (Knoxville, Tenn.) (NYSE: TMH) is one of the largest providers of outsourced physician staffing solutions for hospitals in the United States.  Through its 19 regional locations and multiple service lines, TeamHealth's approximately 9,700 affiliated healthcare professionals provide emergency medicine, hospital medicine, anesthesia, urgent care, and pediatric staffing and management services to approximately 860 civilian and military hospitals, clinics, and physician groups in 46 states.

Forward Looking Statements

Statements and information contained herein that are not historical facts and that reflect the current view of the Company about future events and financial performance are hereby identified as "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Some of these statements can be identified by terms and phrases such as "anticipate," "believe," "intend," "estimate," "expect," "continue," "could," "should," "may," "plan," "project," "predict" and similar expressions.  The Company cautions  that such "forward looking statements," including without limitation, those relating to the Company's future business prospects, revenue, working capital, professional liability expense, liquidity, capital needs, interest costs and income, wherever they occur in this or in other statements attributable to the Company, are necessarily estimates reflecting the judgment of the Company's senior management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the "forward looking statements."  Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements include but are not limited to current or future government regulation of the healthcare industry, exposure to professional liability lawsuits and governmental agency investigations, the adequacy of insurance coverage and insurance reserves, as well as those factors detailed under the caption "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's most recent annual report on Form 10-K and the most recent quarterly report on Form 10-Q filed with the Securities and Exchange Commission.  The Company's "forward looking statements" speak only as of the date hereof and the Company disclaims any intent or obligation to update "forward looking statements" herein to reflect changed assumptions, the occurrence of unanticipated events, or changes to future operating results over time.

Non-GAAP Financial Measures Reconciliations

In this release we refer to Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EPS which are financial measures that are calculated and presented on the basis of methodologies other than in accordance with generally accepted accounting principles in the United States of America ("GAAP").   Adjusted EBITDA is defined as net earnings attributable to Team Health Holdings, Inc. before interest expense, taxes, depreciation and amortization, as further adjusted to exclude the non-cash items and the other adjustments shown in the table under "Adjusted EBITDA" below.  Adjusted EBITDA margin represents Adjusted EBITDA divided by net revenue.  Adjusted EPS is defined as diluted earnings per share attributable to Team Health Holdings, Inc. excluding non-cash and other adjustments, including the impact of contingent purchase and other acquisition compensation expense and amortization expense relating to purchase accounting for historical acquisitions and the other adjustments shown in the table under "Adjusted Earnings Per Share."  For a reconciliation of each of Adjusted EBITDA and Adjusted EPS to the most directly comparable GAAP measure, we refer you to the tables under "Adjusted EBITDA" and "Adjusted Earnings Per Share," respectively.

 

Team Health Holdings, Inc.

Consolidated Balance Sheets



December 31, 2012


December 31, 2013


(Unaudited)

(In thousands)

Assets




Current assets:




Cash and cash equivalents

$

41,240



$

32,331


Accounts receivable, less allowance for uncollectibles of $337,049 and $377,644 in 2012 and 2013, respectively

363,779



392,430


Prepaid expenses and other current assets

38,051



35,029


Receivables under insured programs

31,371



22,961


Total current assets

474,441



482,751


Investments of insurance subsidiary

72,315



84,081


Property and equipment, net

49,166



53,434


Other intangibles, net

137,944



173,178


Goodwill

337,600



428,311


Deferred income taxes

40,189



44,546


Receivables under insured programs

47,886



39,532


Other

48,448



55,577



$

1,207,989



$

1,361,410


Liabilities and shareholders' equity




Current liabilities:




Accounts payable

$

25,046



$

27,700


Accrued compensation and physician payable

180,127



201,998


Other accrued liabilities

132,115



128,749


Income tax payable

1,082



3,014


Current maturities of long-term debt

16,250



17,969


Deferred income taxes

39,489



39,063


Total current liabilities

394,109



418,493


Long-term debt, less current maturities

501,563



483,594


Other non-current liabilities

186,260



190,842


Shareholders' equity:




Common stock, ($0.01 par value; 100,000 shares authorized, 67,763 and 70,016 shares issued and outstanding at December 31, 2012 and 2013, respectively)

678



700


Additional paid-in capital

587,143



642,633


Accumulated deficit

(464,002)



(376,593)


Accumulated other comprehensive earnings

1,701



447


Team Health Holdings, Inc. shareholders' equity

125,520



267,187


Noncontrolling interest

537



1,294


Total shareholders' equity including noncontrolling interest

126,057



268,481



$

1,207,989



$

1,361,410


 

Team Health Holdings, Inc.

Consolidated Statements of Comprehensive Earnings




Three Months Ended December 31,


2012


2013


(Unaudited)(In thousands, except per share data)

Net revenues before provision for uncollectibles

$

983,210



$

1,128,808


Provision for uncollectibles

438,370



507,018


Net revenues

544,840



621,790


Cost of services rendered (exclusive of depreciation and amortization shown separately below)




Professional service expenses

429,236



488,250


Professional liability costs

14,514



18,985


General and administrative expenses (includes contingent purchase and other acquisition compensation expense of $10,707 and $5,394 in 2012 and 2013, respectively)

60,765



62,295


Other income

(280)



(1,691)


Depreciation

3,883



4,512


Amortization

8,258



10,517


Interest expense, net

4,657



3,547


Loss on refinancing of debt

194



-


Transaction costs

576



2,220


Earnings before income taxes

23,037



33,155


Provision for income taxes

8,221



11,667


     Net earnings

14,816



21,488


Net earnings attributable to noncontrolling interest

37



13


Net earnings attributable to Team Health Holdings, Inc.

$

14,779



$

21,475






Net earnings per share of Team Health Holdings, Inc.




Basic

$

0.22



$

0.31


Diluted

$

0.21



$

0.30


Weighted average shares outstanding




Basic

67,352



69,663


Diluted

69,136



71,245






Other comprehensive loss, net of tax:




Net change in fair value of investments, net of tax of $(98) and $(39) for 2012 and 2013, respectively

(183)



(73)


Comprehensive earnings

14,633



21,415


Comprehensive earnings attributable to noncontrolling interest

37



13


Comprehensive earnings attributable to Team Health Holdings, Inc.

$

14,596



$

21,402


 

Team Health Holdings, Inc.

Consolidated Statements of Comprehensive Earnings



For The Year Ended December 31,


2012


2013


(Unaudited)

(In thousands, except per share data)

Net revenues before provision for uncollectibles

$

3,738,696



$

4,313,848


Provision for uncollectibles

1,669,673



1,930,253


Net revenues

2,069,023



2,383,595


Cost of services rendered (exclusive of depreciation and amortization shown separately below)




Professional service expenses

1,611,884



1,867,817


Professional liability costs

71,556



74,185


General and administrative expenses (includes contingent purchase and other acquisition compensation expense of $36,850 and $23,962 in 2012 and 2013, respectively)

220,799



228,911


Other income

(4,757)



(4,536)


Depreciation

14,495



17,070


Amortization

29,765



37,550


Interest expense, net

16,339



14,910


Loss on refinancing of debt

194



-


Transaction costs

4,368



3,809


Earnings before income taxes

104,380



143,879


Provision for income taxes

40,571



56,313


  Net earnings

63,809



87,566


Net earnings attributable to noncontrolling interest

37



157


Net earnings attributable to Team Health Holdings, Inc.

$

63,772



$

87,409






Net earnings per share of Team Health Holdings, Inc.




Basic

$

0.96



$

1.27


Diluted

$

0.93



$

1.24


Weighted average shares outstanding




Basic

66,371



68,988


Diluted

68,277



70,624






Other comprehensive loss, net of tax:




Net change in fair value of investments, net of tax of $(861) and $(676) for 2012 and 2013, respectively

(1,601)



(1,254)


Comprehensive earnings

62,208



86,312


Comprehensive earnings attributable to noncontrolling interest

37



157


Comprehensive earnings attributable to Team Health Holdings, Inc.

$

62,171



$

86,155


 

Team Health Holdings, Inc.

Consolidated Statements of Cash Flows



Three Months Ended December 31,


2012


2013


(Unaudited)

(In thousands)

Operating Activities




Net earnings

$

14,816



$

21,488


Adjustments to reconcile net earnings:




Depreciation

3,883



4,512


Amortization

8,258



10,517


Amortization of deferred financing costs

235



254


Equity based compensation expense

1,955



2,901


Provision for uncollectibles

438,370



507,018


Deferred income taxes

(14,987)



(10,866)


Loss on refinancing of debt

50



-


Equity in joint venture income

944



912


Changes in operating assets and liabilities, net of acquisitions:




Accounts receivable

(429,498)



(509,544)


Prepaids and other assets

(6,699)



1,841


Income tax accounts

4,681



973


Accounts payable

3,459



6,959


Accrued compensation and physician payable

16,186



18,688


Contingent purchase liabilities

4,580



(24,523)


Other accrued liabilities

10,416



3,433


Professional liability reserves

(8,695)



5,160


Net cash provided by operating activities

47,954



39,723


Investing Activities




Purchases of property and equipment

(6,310)



(9,815)


Cash paid for acquisitions, net

(21,108)



(136,708)


Purchases of investments by insurance subsidiary

(20,744)



(18,161)


Proceeds from investments by insurance subsidiary

14,473



13,995


Net cash used in investing activities

(33,689)



(150,689)


Financing Activities




Payments on notes payable

(4,062)



(4,062)


Proceeds from notes payable

134,375



-


Proceeds from revolving credit facility

53,000



-


Payments on revolving credit facility

(176,000)



-


Stock issuance costs

(198)



-


Payments of financing costs

(2,810)



-


Contribution from noncontrolling interest

500



-


Proceeds from the issuance of common stock under stock purchase plans

1,013



1,548


Proceeds from exercise of stock options

7,236



4,137


Tax benefit from exercise of stock options

6,850



9,666


Net cash provided by financing activities

19,904



11,289


Net increase (decrease) in cash and cash equivalents

34,169



(99,677)


Cash and cash equivalents, beginning of period

7,071



132,008


Cash and cash equivalents, end of period

$

41,240



$

32,331


Supplemental cash flow information:




Interest paid

$

4,530



$

3,857


Taxes paid

$

12,842



$

12,310


 

Team Health Holdings, Inc.

Consolidated Statements of Cash Flows



For The Year Ended

December 31,


2012


2013


(Unaudited) 

 (In thousands)

Operating Activities




Net earnings

$

63,809



$

87,566


Adjustments to reconcile net earnings:




Depreciation

14,495



17,070


Amortization

29,765



37,550


Amortization of deferred financing costs

831



1,018


Equity based compensation expense

6,777



9,889


Provision for uncollectibles

1,669,673



1,930,253


Deferred income taxes

(10,995)



(10,729)


Loss on refinancing of debt

50



-


(Gain) loss on disposal or sale of equipment

(61)



79


Equity in joint venture income

(1,257)



(1,811)


Changes in operating assets and liabilities, net of acquisitions:




Accounts receivable

(1,707,691)



(1,943,669)


Prepaids and other assets

(12,651)



(2,367)


Income tax accounts

2,520



1,932


Accounts payable

184



2,025


Accrued compensation and physician payable

25,039



20,719


Contingent purchase liabilities

13,353



(10,589)


Other accrued liabilities

(4,698)



(2,341)


Professional liability reserves

(17,585)



17,814


Net cash provided by operating activities

71,558



154,409


Investing Activities




Purchases of property and equipment

(22,005)



(21,378)


Sale of property and equipment

171



125


Cash paid for acquisitions, net

(167,637)



(159,140)


Purchases of investments by insurance subsidiary

(159,657)



(86,773)


Proceeds from investments by insurance subsidiary

179,180



73,077


Other investing activities

(2,000)



-


Net cash used in investing activities

(171,948)



(194,089)


Financing Activities




Payments on notes payable

(11,562)



(16,250)


Proceeds from notes payable

134,375



-


Proceeds from revolving credit facility

736,600



-


Payments on revolving credit facility

(761,600)



-


Stock issuance costs

(1,304)



(519)


Payments of financing costs

(2,829)



(1)


Contribution from noncontrolling interest

500



600


Proceeds from the issuance of common stock under stock purchase plans

2,067



2,991


Proceeds from exercise of stock options

27,871



30,500


Tax benefit from exercise of stock options

7,657



13,450


Net cash provided by financing activities

131,775



30,771


Net increase (decrease) in cash and cash equivalents

31,385



(8,909)


Cash and cash equivalents, beginning of period

9,855



41,240


Cash and cash equivalents, end of period

$

41,240



$

32,331


Supplemental cash flow information:




Interest paid

$

17,372



$

15,526


Taxes paid

$

43,394



$

52,209


 


Team Health Holdings, Inc.

Adjusted EBITDA

We present Adjusted EBITDA as a supplemental measure of our performance.  We define Adjusted EBITDA as net earnings attributable to Team Health Holdings, Inc. before interest expense, taxes, depreciation and amortization, as further adjusted to exclude the non-cash items and the other adjustments shown in the table below.  We present Adjusted EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance.

Adjusted EBITDA is not a measurement of financial performance or liquidity under generally accepted accounting principles.  In evaluating our performance as measured by Adjusted EBITDA, management recognizes and considers the limitations of this measure.  Adjusted EBITDA does not reflect certain cash expenses that we are obligated to make, and although depreciation and amortization are non-cash charges, assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements.  In addition, other companies in our industry may calculate Adjusted EBITDA differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure.  Because of these limitations, Adjusted EBITDA should not be considered in isolation or as a substitute for net earnings, operating income, cash flows from operating, investing or financing activities, or any other measure calculated in accordance with generally accepted accounting principles.

The following table sets forth a reconciliation of net earnings attributable to Team Health Holdings, Inc. to Adjusted EBITDA.

 


Three Months Ended

 December 31,


For The Year Ended

December 31,


2012


2013


2012


2013


(In thousands)

Net earnings attributable to Team Health Holdings, Inc.

$

14,779



$

21,475



$

63,772



$

87,409


Interest expense, net

4,657



3,547



16,339



14,910


Provision for income taxes

8,221



11,667



40,571



56,313


Depreciation

3,883



4,512



14,495



17,070


Amortization

8,258



10,517



29,765



37,550


Other income(a)

(280)



(1,691)



(4,757)



(4,536)


Loss on refinancing of debt(b)

194



-



194



-


Contingent purchase and other acquisition compensation expense(c)

10,707



5,394



36,850



23,962


Transaction costs(d)

576



2,220



4,368



3,809


Equity based compensation expense(e)

1,955



2,901



6,777



9,889


Insurance subsidiary interest income

342



488



1,883



1,795


Professional liability loss reserve adjustments associated with prior years

-



-



5,165



-


Severance and other charges

760



833



2,822



3,097


Adjusted EBITDA

$

54,052



$

61,863



$

218,244



$

251,268


















(a) Reflects gain or loss on sale of assets, realized gains on investments, and changes in fair value of investments associated with the Company's non-qualified retirement plan.

(b) Reflects the write-off of deferred financing costs of $50 from the previous term loan as well as certain fees and expenses associated with the debt refinancing in 2012.

(c) Reflects expense recognized for historical and estimated future contingent payments and other compensation expense associated with acquisitions.

(d) Reflects expenses associated with accounting, legal, due diligence and other transaction fees related to acquisition activity.

(e) Reflects costs related to options and restricted shares granted under the Team Health Holdings, Inc. 2009 Amended and Restated Stock Incentive Plan.

 

Team Health Holdings, Inc.

Adjusted Earnings Per Share

(in thousands, except per share data)

We present Adjusted earnings per share attributable to Team Health Holdings, Inc. ("Adjusted EPS") as a supplemental measure of our performance.  We define Adjusted EPS as diluted earnings per share excluding non-cash and other adjustments, including the impact of contingent purchase and other acquisition compensation expense and amortization expense relating to purchase accounting for historical acquisitions.  We present Adjusted EPS because we believe that it assists investors in understanding the impact of acquisition-related costs on our earnings per share and comparing our performance across operating periods on a consistent basis and provides additional insight into our core earnings performance.  Adjusted EPS is not a measurement of financial performance or liquidity under generally accepted accounting principles.  In evaluating our performance as measured by Adjusted EPS, management recognizes and considers the limitations of this measure.  Adjusted EPS does not reflect certain cash expenses that we are obligated to make, and although contingent purchase compensation expense and amortization expense are non-cash charges in the period reported, such charges reflect historical or future cash payments in conjunction with our acquisition transactions.  In addition, other companies in our industry may calculate Adjusted EPS differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure.  Because of these limitations, Adjusted EPS should not be considered in isolation or as a substitute for net earnings, operating income, basic and diluted earnings per share, cash flows from operating, investing or financing activities, or any other measure calculated in accordance with generally accepted accounting principles.

The following tables set forth a reconciliation of diluted earnings per share to Adjusted EPS (note that some totals may not add due to rounding).

 


Three Months Ended December 31,


2012


2013

Diluted weighted average shares outstanding

69,136





71,245




Net earnings and diluted net earnings per share attributable to Team Health Holdings, Inc., as reported

$

14,779



$

0.21



$

21,475



$

0.30


Adjustments:








Loss on refinancing of debt, net of tax of $(77) for 2012

117



-



-



-


Contingent purchase and other acquisition compensation expense, net of tax of $(4,084) and $(1,286) for 2012 and 2013, respectively

6,623



0.10



4,108



0.06


Amortization expense, net of tax of $(2,995) and $(3,450) for 2012 and 2013, respectively

5,263



0.08



7,067



0.10


Net earnings and diluted earnings per share attributable to Team Health Holdings, Inc., as adjusted

$

26,782



$

0.39



$

32,650



$

0.46


 


For The Year Ended December 31,


2012


2013

Diluted weighted average shares outstanding

68,277





70,624




Net earnings and diluted net earnings per share attributable to Team Health Holdings, Inc., as reported

$

63,772



0.93



$

87,409



1.24


Adjustments:








Professional liability loss reserve adjustments associated with prior years, net of tax of $(2,051) for 2012

3,114



0.05



-



-


Loss on refinancing of debt, net of tax of $(77) for 2012.

117



-



-



-


Contingent purchase and other acquisition compensation expense, net of tax of $(14,043) and $(7,336) for 2012 and 2013, respectively

22,807



0.33



16,626



0.24


Amortization expense, net of tax of $(10,894) and $(12,538) for 2012 and 2013, respectively

18,871



0.28



25,012



0.35


Net earnings and diluted earnings per share attributable to Team Health Holdings, Inc., as adjusted

$

108,681



$

1.59



$

129,047



$

1.83


















Team Health Holdings, Inc.

Revenue Analysis

The components of net revenue include revenue from contracts that have been in effect for prior periods (same contracts) and from net, new and acquired contracts during the periods, as set forth in the table below:

 


Three Months Ended December 31,


2012


2013


(in thousands)

Same contracts:




Fee for service revenue

$

354,157



$

368,797


Contract and other revenue

146,272



143,792


Total same contracts

500,429



512,589


New contracts, net of terminations:




Fee for service revenue

26,444



39,476


Contract and other revenue

15,202



17,344


Total new contracts, net of terminations

41,646



56,820


Acquired contracts:




Fee for service revenue

2,604



42,942


Contract and other revenue

161



9,439


Total acquired contracts

2,765



52,381


Consolidated:




Fee for service revenue

383,205



451,215


Contract and other revenue

161,635



170,575


Total net revenue

$

544,840



$

621,790


The following table reflects the visits and procedures included within fee for service revenues described in the table above:

 


Three Months Ended December 31,


2012


2013


(in thousands)

Fee for service visits and procedures:




Same contract

2,361



2,285


New and acquired contracts, net of terminations

231



491


Total fee for service visits and procedures

2,592



2,776


 

Team Health Holdings, Inc.

Revenue Analysis

The components of net revenue include revenue from contracts that have been in effect for prior periods (same contracts) and from net, new and acquired contracts during the periods, as set forth in the table below:

 


For The Year Ended December 31,


2012


2013


(in thousands)

Same contracts:




Fee for service revenue

$

1,251,737



$

1,314,978


Contract and other revenue

418,767



414,554


Total same contracts

1,670,504



1,729,532


New contracts, net of terminations:




Fee for service revenue

167,168



192,367


Contract and other revenue

124,657



167,089


Total new contracts, net of terminations

291,825



359,456


Acquired contracts:




Fee for service revenue

71,752



200,948


Contract and other revenue

34,942



93,659


Total acquired contracts

106,694



294,607


Consolidated:




Fee for service revenue

1,490,657



1,708,293


Contract and other revenue

578,366



675,302


Total net revenue

$

2,069,023



$

2,383,595


The following table reflects the visits and procedures included within fee for service revenues described in the table above:

 


For The Year Ended December 31,


2012


2013


(in thousands)

Fee for service visits and procedures:




Same contract

8,530



8,396


New and acquired contracts, net of terminations

1,723



2,388


Total fee for service visits and procedures

10,253



10,784


 

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

All content © Copyright 2000 - 2014 Worldnow and WBOC. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service